Log In
Print
BCIQ
Print
Print this Print this
 

MM-111

  Manage Alerts
Collapse Summary General Information
Company Merrimack Pharmaceuticals Inc.
DescriptionBispecific antibody targeting epidermal growth factor receptor 3 (EGFR3; HER3; ErbB3) and EGFR2
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3) ; Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today